Miaoshou Yiku News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China’s Yuanxin Technology nets $465m funding from Tencent, Sequoia, others
February 9, 2021
Beijing Yuanxin Technology Co., Ltd, a specialist in digital healthcare and chain pharmacies, has raised 3 billion yuan ($465 million) in a Series E round co-led by existing investors Tencent and Sequoia Capital China.
The round attracted a slew of investors from primary and secondary markets, according to a company statement on Tuesday.
Existing investors including state-backed CITIC Group’s brokerage firm CITIC Securities, Qiming Venture Partners, Index Capital, and Kunling Capital re-upped in the round, while new investors who participated included CICC Capital, New York-based fund manager OrbiMed, Noah Holdings’ alternative asset manager Gopher Asset Management, and E Fund. ....

Yuanxin Huibao , Miaoshou Yiku , Noah Holding , Yuanxin Technology Co Ltd , Yuanxin Medical Technology , De Fund , Sequoia Capital , Qiming Venture Partners , Index Capital , Kunling Capital , New York Based , Gopher Asset Management , State Council , Miaoshou Doctor , Yuanxin Pharmacy , Capital China , Starquest Capital , நோவா வைத்திருத்தல் , ஏ நிதி , சீக்வோயா மூலதனம் , குறியீட்டு மூலதனம் , புதியது யார்க் அடிப்படையிலானது , கோபேர் சொத்து மேலாண்மை , நிலை சபை , மூலதனம் சீனா , ஸ்டார்க்வெஸ்ட் மூலதனம் ,